default author photo

Shaoqi Yang

Ningxia Medical University - General Hospital

Yinchuan, 750004

China

SCHOLARLY PAPERS

2

DOWNLOADS

145

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Rifasutenizol, a Novel Antimicrobial Agent with a Dual Mechanism of Action, for the First-Line Treatment of Helicobacter Pylori Infection (EVEREST-HP): A Multicenter, Randomized, Double-Blind, Controlled, Non-Inferiority Phase 3 Trial

Number of pages: 36 Posted: 18 Jun 2025
Peking University - Peking University Third Hospital, Peking University - Peking University Third Hospital, Peking University - Peking University First Hospital, Hainan Medical University - Hainan General Hospital, Jilin University (JLU) - First Hospital, Gannan Medical University - First Affiliated Hospital, The People's Hospital of Yichun City, Qinghai University - Qinghai University Affiliated Hospital, Shandong University - Qilu Hospital, Nanchang University, Binzhou Medical University - Binzhou Medical University Hospital, Chizhou People's Hospital, Soochow University - First Affiliated Hospital, Sun Yat-sen University (SYSU) - Department of Gastroenterology, Yangtze University - First Affiliated Hospital, Jilin University (JLU) - First Hospital, TenNor Therapeutics, TenNor Therapeutics, Quzhou People's Hospital, Bengbu Medical University, University of South China - First Affiliated Hospital, The Second People’s Hospital of Lianyungang, Yangtze University - Jingzhou Central Hospital, Hebei General Hospital, Jiangsu University - Affiliated Hospital, Pingxiang People's Hospital, Zhejiang University - Second Affiliated Hospital, Xiamen University - First Affiliated Hospital, Huizhou Central People's Hospital, Ningxia Medical University - General Hospital, Xiamen University - Zhongshan Hospital, Central South University - Xiangya Hospital, Haikou People’s Hospital, University of Jinan, Subei People’s Hospital, Sun Yat-sen University (SYSU) - Department of Gastroenterology and Hepatology, Nanjing Medical University - Wuxi People’s Hospital, Shandong First Medical University, Wuhan University - Renmin Hospital, Tongji University, Fudan University - Zhongshan Hospital, South China University of Technology - Guangzhou First People's Hospital, Zhengzhou University - Fifth Affiliated Hospital and TenNor Therapeutics
Downloads 82 (809,932)

Abstract:

Loading...

Rifasutenizole, Helicobacter pylori, Antimicrobial resistance, Gastric cancer

2.

Trends in Medication Use and Treatment Patterns in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Cohort Study from 1999 to 2020

Number of pages: 26 Posted: 29 Nov 2021
Zhejiang University, Zhejiang University - Department of Gastroenterology, China Medical University - Shengjing Hospital, Wuhan University, Jilin University (JLU), Tongji University - Department of Gastroenterology, Xiamen University - Department of Gastroenterology, Ningxia Medical University - General Hospital, Guangxi Medical University - First Affiliated Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Central South University - Second Xiangya Hospital, Nanjing University - Nanjing Drum Tower Hospital, Government of the People's Republic of China - Department of Gastroenterology and Zhejiang University - Department of Gastroenterology
Downloads 63 (933,592)

Abstract:

Loading...

inflammatory bowel disease, medication use, treatment pattern, Chinese population